Pure Global
NCT06403280

The Effect of Alcohol on Common Tremor Syndromes

The Effect of Alcohol on Common Tremor Syndromes - A Prospective Double-blind Randomised Cross-over (Alcohol, Placebo) Study
Medical University of Graz·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Essential Tremor,Dystonia,Parkinson Disease
Drug/Device/Intervention
Alcoholic drink
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Medical University of Graz
Location
Graz, Austria
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Apr 01, 2025
Enrollment
45 participants
Primary outcome

Change from baseline of the Total Tremor Power measured by accelerometry

Summary

The aim of this interventional study is to compare the response to alcohol in patients with
 essential tremor (ET), essential tremor plus (ETplus), dystonic tremor (DT), tremor
 associated with dystonia (TaD) and tremor in Parkinson´s disease (PD). The main question to
 be answered is:
 
 • Is there a difference in the objective alcohol responsiveness of patients with ET, DT, TaD
 and PD?
 
 Participants will receive either vodka with rum-flavoured orange juice with a target blood
 alcohol of 0.4 ‰ or a non-alcoholic rum-flavoured orange juice (vice versa on the second
 study day). Before and 30, 60 an 120 minutes after the study drink the participants will
 undergo a clinical examination of the tremor and accelerometry will be performed.
 
 Researchers will compare alcohol and placebo in a randomized cross over way to see if the
 effect of alcohol on tremor exceeds the placebo effect.

ICD-10 classifications
Essential tremorOther dystoniaOther specified forms of tremorDystonia, unspecifiedDystonia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06403280
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06403280 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Not yet recruiting. The study focuses on Essential Tremor,Dystonia,Parkinson Disease. Target enrollment is 45 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.